Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?

Ordu, Çetin; Selcuk, Nalan; ERDOĞAN, EZGİ; Angın, Gülden; Güral, Zeynep; Memiş, Hatice; Yencilek, E; Dalsuna, Sinem; Pilancı, K

doi:10.1097/md.0000000000000299

Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?

Ordu Ç., Selcuk N. A., ERDOĞAN E. B., Angın G., Güral Z., Memiş H., ...More

MEDICINE, vol.93, no.28, 2014 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 93 Issue: 28
Publication Date: 2014
Doi Number: 10.1097/md.0000000000000299
Journal Name: MEDICINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Open Archive Collection: AVESIS Open Access Collection
Bezmialem Vakıf University Affiliated: Yes

Abstract

The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC).